Please see list below for complete list of fellowship positions offered for the 2022-2023 fellowship cycle. For more information on the application process, please visit the MCPHS website’s Application Page.
MCPHS/Agios
- Clinical Supply Chain
- Medical Safety Risk Management
- Regulatory Affairs
- Clinical Development GMP – Quality Assurance
MCPHS/Alexion
- Global Value Access and Pricing
- Global Patient Safety
- Global Medical Communications / Global Medical Affairs
- Global Regulatory Affairs
- US Medical Affairs
MCPHS/Biogen
- Global Safety
- Regulatory Sciences
- Regulatory Sciences: Advertising & Promotion
- Regulatory Sciences: Global Medical Writing
- US Marketing
- US Medical
- Worldwide Medical
- Therapeutics Development
MCPHS/Moderna
- Clinical Development Operations
- Global Regulatory Science
- Clinical Safety & Pharmacovigilance
MCPHS/Novartis
- Biomarker Development (BMD)
- Clinical Operations: General Medicine
- Clinical Operations: Translational Clinical Oncology (TCO)
- Regulatory Affairs (RA)
MCPHS/Pfizer
- Clinical Research Pharmacy
MCPHS/Sanofi
- Global/US Commercial Strategy: Rare Diseases
- Global/US Commercial Strategy: Oncology
- Global Scientific/Medical Communications: Rare Diseases
- Global Scientific/Medical Communications: Oncology
- Global Scientific/Medical Communications: Immunology
- Global Scientific/Medical Communications: Neurology
- Global Scientific/Medical Communications: Rare Blood Disorders
- Global/US Medical: Oncology
- US Medical/Medical Director: Neurology
- US Medical/Medical Science Liaison: Neurology
- US Medical/Medical Science Liaison: Rare Diseases
- US Medical/Medical Science Liaison: Immunology
- US Medical Value & Outcomes
- Global Pharmacovigilance
- Global Regulatory Affairs
- Clinical Documentation/Medical Writing
MCPHS/Sunovion
- Medical Affairs / Scientific Communications
MCPHS/Takeda
- Global Clinical Supply Chain
- Global Medical Communications – Global Medical Affairs, Oncology
- Global Medical Information & Review (Oncology) (1 year)
- Global Pharmacovigilance